共 23 条
- [1] Vanittanakom N(2006) infection and recent advances in the epidemiology and molecular biology aspects Clin Microbiol Rev 19 95-110
- [2] Cooper CR(2010)Rituximab-associated infections Semin Hematol 47 187-198
- [3] Fisher MC(2014)Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions N Engl J Med 370 1101-1110
- [4] Sirisanthana T(2013)Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large B-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study J Clin Oncol 31 2912-2919
- [5] Gea-Banacloche JC(2013)Obinutuzumab (GA101) in patients with relapsed/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN study J Clin Oncol 31 2920-2926
- [6] Goede V(2012)CD20 antibodies: type II to tango? Blood 119 5061-5063
- [7] Fischer K(2013)Minireview: host defence in invasive aspergillosis Mycoses 56 403-413
- [8] Busch R(2014)B cells participate in tolerance and autoimmunity through cytokine production Autoimmunity 47 1-12
- [9] Morschhauser FA(undefined)undefined undefined undefined undefined-undefined
- [10] Cartron G(undefined)undefined undefined undefined undefined-undefined